ROS/RNS as Molecular Signatures of Chronic Liver Diseases

The authors discuss the reactive oxygen/nitrogen species (ROS/RNS)-related mechanisms underlying liver fibrosis of distinct etiologies and highlight preclinical and clinical trials of antifibrotic therapies premised on remediating oxidative/nitrosative stress in hepatocytes or targeting hepatic stellate cell activation.